Alan Meds
Alan Health, also known as Alan Meds, advertises compounded injection and sublingual options alongside branded prescription options.
Our take
Alan is a reasonable comparison if you want a choice of preparations and ongoing online care. We would settle the payment term and actual renewal-processing date first. Its lowest advertised equivalents require prepayment, and cancelling another charge does not recover unused treatment.
- Semaglutide
- $158/mo equivalent (2-month upfront promotion, compounded)
- Tirzepatide
- $325/mo equivalent (6-month upfront plan, compounded)
- Coverage
- Eligibility depends on state, prescription and pharmacy
- Brand-name
- Yes
Weigh Alan Meds against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives.
Semaglutide advertises $158/month with two months paid upfront under a promotion; tirzepatide advertises $325/month with six months prepaid. These are advertised equivalents, not verified monthly card charges. Confirm the first payment, renewal amount and supplied quantity.
Start with the payment term
The semaglutide page pairs $158/month with a buy-one-month, get-one-free offer and two-month prepayment. Its separate $315 display does not settle your first charge or post-promotion renewal. Get those amounts before using our six-month cost guide to compare plans.
Tirzepatide's $325 starting label requires six-month prepayment. The advertised price stays the same across doses, but that does not establish monthly billing or your individual prescription. We would compare a shorter commitment before prepaying if you are still deciding whether the service suits you.
The $215/month oral offer also requires six months prepaid. The page describes sublingual compounded semaglutide dissolved under the tongue. It is a separate compounded preparation, not an FDA-approved oral product or evidence of the same outcomes as injections.
The renewal can arrive before the next treatment period
Alan's terms allow the first renewal to process up to five business days early. Cancellation must arrive at least three business days before renewal processing; partly used periods are not refundable. Confirm the actual processing date and set a reminder around it. Our cancellation guide separates avoiding the next debit from recovering an earlier one.
The Help page promises a full refund after clinical rejection. It also says an order cannot be cancelled once medical review has been submitted and processing begins, and prescription sales are final. Ask what happens to your payment at each stage.
Medical consent instead says all programs auto-renew with no refunds or exchanges. That broader statement needs reconciling with the rejection-refund promise if you depend on it. We cannot establish which document would control a dispute.
Confirm the preparation, not just the medication name
The semaglutide page discusses B12 and B6 additives. Request the exact ingredients and concentration rather than assuming the advertised preparation is what you will receive. The vial-label guide explains why concentration and syringe units need separate checks.
The tirzepatide page says preparations may include B6, B12, glycine and NAD+. This does not identify your ingredients or usable supply, or establish an extra clinical benefit from those additives.
Brand-name options need their own quote
The public catalog also lists branded Wegovy and Zepbound injections. Its product cards lead to clinical intake; they do not settle whether a selected price covers medication, care alone or both. Compare the pharmacy bill, care fee and testing separately before comparing a branded route with the compounded plans.
Separate the platform from the clinicians and compounder
Alan Health Technologies Inc., doing business as Alan Meds and Alan Health, is the stated platform operator. The site names MDI Medical Group P.C. and Alan Medical Group P.C. among independent physician networks and says Alan does not provide medical or pharmacy services. Ask who will actually prescribe and dispense for you.
The Help page permits a partner pharmacy or a licensed pharmacy of your choice, with outside-pharmacy charges paid separately. Use our pharmacy verification guide to check the named facility; a preferred pharmacy and the advertised bundle do not establish the same total cost.
Read the dated FDA record alongside current pharmacy information
FDA issued a February 20, 2026 warning letter to Alan Health Technologies Inc. dba Alan. Read that dated record alongside the current pharmacy information before deciding. We have not verified a later close-out or established the company's present regulatory status.
Factor breakdown
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.
Strengths
- Advertised compounded injection pricing stays the same across doses
- Online care with a choice of injection and sublingual preparations
- Outside-pharmacy choice described; separate charges may apply
- Public catalog lists branded Wegovy and Zepbound options
What to consider
- Lowest compounded price labels require upfront multi-month payment
- First renewal may process early; cancel before the actual processing deadline
- Unused subscription periods are not refundable under the ordinary terms
- Rejection-refund promise differs from broader medical-consent wording
Bottom line — Grade C
Best for: Self-pay adults comfortable with online prescribing who can confirm eligibility, the treatment term and dispensing pharmacy before paying.
Look elsewhere if: Anyone needing monthly billing at the lowest headline, unused prepayment refunded, or an FDA-approved product from the compounded oral offer.
Site position #238 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.
FDAWarning letter issued to Alan Health Technologies Inc. dba Alan in February 2026. See the FDA warning-letter database.
Closest here
The rankings grading nearest Alan Meds — the realistic shortlist.
Neo Soma Healthcare is a multi-product DTC telehealth platform pairing compounded GLP-1 weight management with sexual-health and anti-aging lines.
Zeuss is a multi-vertical telehealth platform offering compounded semaglutide and tirzepatide for weight loss alongside TRT, HRT, skin, and hair services.
FMmeds is a Manhattan Beach-based DTC telehealth platform selling compounded semaglutide and tirzepatide co-formulated with vitamin B12, with no membership fee and a free initial visit billed only on approval.
Eloria is a clinician-led GLP-1 weight-loss telehealth platform operated by Arora Health & Aesthetics.
FuturHealth Inc. is a San Diego-based telehealth weight management brand offering brand-name Ozempic, Wegovy (injection AND oral pill), Mounjaro, Zepbound, and Foundayo (orforglipron oral pill, added Q2 2026) plus clinician-discretionary compounded GLP-1/GIP combinations, dispensed through US-based licensed pharmacies.
Healthicare is a GLP-1 telehealth platform offering both compounded options and a full brand-name menu — Ozempic, Wegovy, Mounjaro, and Zepbound — on a single account.
The 20 rankings nearest this one
- #243 NowPatient65.5
- #244 Options Medical Weight Loss65.5
- #245 Primary Clinic (Direct GLP)65.5
- #246 Shapely65.4
- #247 Enara Health65.3
- #248 RestorLife Med65.3
- #249 Roboclinic65.3
- #250 Dr. Arevitalize65.2
- #251 Mixx Health & Wellness65.2
- #252 Southern Vitality and Weight Loss65.2
- #253 Intimate Rose65.1
- #254 Vital Edge65
- #255 BetterMe Rx64.9
- #256 Livv64.9
- #257 QuickMD64.9
- #258 Vita Bella64.9
- #259 Better U Care64.8
- #260 NEUVÉ Health64.7
- #261 Rylo Health64.7
- #262 Injectco64.6
Pricing/verification reflect Alan Meds's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Alan Meds's site. Not medical advice; see our disclosure.